Mind Relief

Health Shared Services is a part of Ontario Health, focused on supporting health system integration. HSSOntario is committed to treating all people in a way that maintains their dignity and independence. They support integration and equal opportunity and are committed to meeting the needs of people with disabilities.

GoodCap develops low-dose psilocybin products to help people suffering from depression. They provide targeted depression and the gut-brain axis on reducing inflammation as a source of a broad array of physiology and disease in the body. They combine low-dose psilocybin with synergistic potentiator molecules to amplify anti-inflammatory properties. Their therapies are designed for regular at-home dosing, reducing the time and cost compared to high-dose psilocybin approaches that require significant health care and psychotherapy sessions.

Provis Infusion Clinic Inc., located in downtown Toronto, Canada, has been a leading provider of comprehensive infusion services since 2005, administering over 13,000 infusions to date. The clinic boasts an experienced team of oncology-trained nurses and pharmacists, and is equipped with an onsite medication compounding facility. Recognized for its extensive oncology drug formulary, Provis is dedicated to offering high-quality care while participating in significant clinical trials, such as the COVID-19 "Cobra" trial. Additionally, Provis collaborates with various patient support programs to provide financial assistance for qualified patients in need of a range of oncology treatments. Generated from the website